Pegvisomant in acromegaly: a multicenter real-life study in Argentina

OBJECTIVE: To describe the long term safety and efficacy of pegvisomant (PEGV), and the predictors of treatment response in patients with acromegaly in the real life setting. SUBJECTS AND METHODS: We retrospectively reviewed the clinical, hormonal and radiological data of acromegalic patients treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Basavilbaso, Natalia Ximena Garcia, Ballarino, Maria Carolina, Bruera, Darío, Bruno, Oscar D., Chervin, Alberto B., Danilowicz, Karina, Fainstein-Day, Patricia, Fidalgo, Silvina Gabriela, Frigeri, Adriana, Glerean, Mariela, Guelman, Rodolfo, Isaac, Gabriel, Katz, Debora Adela, Knoblovits, Pablo, Librandi, Fabiana, Montes, Monica López, Mallea-Gil, Maria Susana, Manavela, Marcos, Mereshian, Paula, Moncet, Daniel, Pignatta, Analia, Rogozinsky, Amelia, Sago, Laura R., Servidio, Marisa, Spezzi, Monica, Stalldecker, Graciela, Tkatch, Julieta, Vitale, Nicolas Marcelo, Guitelman, Mirtha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528651/
https://www.ncbi.nlm.nih.gov/pubmed/31460622
http://dx.doi.org/10.20945/2359-3997000000160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528651/
https://www.ncbi.nlm.nih.gov/pubmed/31460622
http://dx.doi.org/10.20945/2359-3997000000160

Ejemplares similares